Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
BpnGgvqhMqCCDWk6
